Our study focused on the programmed death-ligand 1 (PD-L1) expression in matched tumour samples and analysed separately PD-L1 expression in tumour cells and immune cells in these three tumour locations by immunohistochemistry using the combined positive score (CPS). Here, CD274 is linked to neoplasm.